Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Non-Current Debt: 2020-2024

Historic Non-Current Debt for P3 Health Partners (PIII) over the last 4 years, with FY2024 value amounting to $108.9 million.

  • P3 Health Partners' Non-Current Debt rose 6076.43% to $214.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.2 million, marking a year-over-year increase of 6076.43%. This contributed to the annual value of $108.9 million for FY2024, which is 54.28% up from last year.
  • Per P3 Health Partners' latest filing, its Non-Current Debt stood at $108.9 million for FY2024, which was up 54.28% from $108.3 million recorded in FY2023.
  • P3 Health Partners' Non-Current Debt's 5-year high stood at $108.9 million during FY2024, with a 5-year trough of $45.4 million in FY2020.
  • In the last 4 years, P3 Health Partners' Non-Current Debt had a median value of $101.4 million in 2022 and averaged $89.3 million.
  • As far as peak fluctuations go, P3 Health Partners' Non-Current Debt skyrocketed by 1471.92% in 2023, and later skyrocketed by 54.28% in 2024.
  • Over the past 4 years, P3 Health Partners' Non-Current Debt (Annual) stood at $45.4 million in 2020, then soared by 108.03% to $94.4 million in 2022, then rose by 14.72% to $108.3 million in 2023, then increased by 0.54% to $108.9 million in 2024.
  • Its Non-Current Debt stands at $108.9 million for FY2024, versus $108.3 million for FY2023 and $94.4 million for FY2022.